{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:09:29Z","timestamp":1789463369109,"version":"build-2803163510"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Ralph C. Wilson, Jr. Foundation"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mild cognitive impairment (MCI) represents a critical window for both pharmacological therapies and non-pharmacological interventions to delay cognitive decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether combining pharmacotherapy with multicomponent behavioral interventions enhances outcomes relative to behavioral interventions alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The sample included people with MCI (pwMCI) of any etiology who completed the HABIT Healthy Action to Benefit Independence &amp; Thinking\n                      <jats:sup>\u00ae<\/jats:sup>\n                      program. Baseline pharmacotherapy (acetylcholinesterase inhibitor and\/or glutamate regulators) use was dichotomized (yes\/no). Multivariate linear mixed-effects models examined changes from baseline in care partner-reported everyday functional skills, quality of life, self-efficacy, anxiety, depression, and HABIT compliance at post-intervention, 6 months, and 12 months, adjusting for baseline cognitive impairment severity and relevant demographic covariates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1074 pwMCI, 413 (38.5%) were receiving pharmacotherapy at baseline. Pharmacotherapy use was more prevalent among White than non-White participants (39.4% versus 23.3%, p\u2009=\u20090.01). At baseline, pharmacotherapy users had more severe cognitive impairment and lower utilization of rehabilitation strategies (all p\u2009&lt;\u20090.05). Both groups demonstrated significant improvements across all outcomes at post-intervention. During follow-up (mean score change compared to baseline), pharmacotherapy users showed greater increases in HABIT compliance at 6 months (3.2 versus 2.0) and 12 months (2.1 versus 1.4). In contrast, by 12 months, pharmacotherapy users experienced greater worsening of everyday functional skills related to memory (\u22122.1 versus \u22121.3) and executive function (\u22125.8 versus-3.7).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>pwMCI undergoing pharmacotherapy entered the HABIT program with more advanced cognitive impairment. The pharmacotherapy was not associated with greater intervention-related benefit or attenuation of long-term cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877261471921","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:10:41Z","timestamp":1785161441000},"page":"959-968","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Does concurrent pharmacotherapy enhance behavioral interventions for mild cognitive impairment? Evidence from the HABIT program"],"prefix":"10.1177","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2007-1706","authenticated-orcid":false,"given":"Zhigang","family":"Xie","sequence":"first","affiliation":[{"name":"University of Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-7716","authenticated-orcid":false,"given":"Dona","family":"Locke","sequence":"additional","affiliation":[{"name":"Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Shandera-Ochsner","sequence":"additional","affiliation":[{"name":"Mayo Clinic Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9050-7267","authenticated-orcid":false,"given":"Hanadi","family":"Hamadi","sequence":"additional","affiliation":[{"name":"University of North Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte","family":"De Wit","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Santos","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Boots","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Aghamoosa","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Grant","sequence":"additional","affiliation":[{"name":"The Ohio State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Chandler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic Florida, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0291-x"},{"key":"e_1_3_3_3_2","unstructured":"Alzheimer\u2019s Association. Mild Cognitive Impairment (MCI) https:\/\/www.alz.org\/alzheimers-dementia\/what-is-dementia\/related_conditions\/mild-cognitive-impairment (accessed 1 February 2026)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05967-w"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001347"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2019.01.004"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004826"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000354370"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2025.10.011"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308112"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111689"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/176051"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000486546"},{"key":"e_1_3_3_14_2","article-title":"Cholinesterase inhibitors for mild cognitive impairment","volume":"2012","author":"Russ TC","year":"2012","unstructured":"Russ TC, Morling JR. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database Syst Rev 2012; 2012: CD009132.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000291"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190546"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2016-096587"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-016-9330-4"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-017-9363-3"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60461-5"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.12923"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01225-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2196\/resprot.8103"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2020.59"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3016"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-171161"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.22.4.531"},{"key":"e_1_3_3_28_2","first-page":"510","article-title":"Assessing quality of life in older adults with cognitive impairment","volume":"64","author":"Logsdon RG","year":"2002","unstructured":"Logsdon RG, Gibbons LE, McCurry SM, et al. Assessing quality of life in older adults with cognitive impairment. Biopsychosoc Sci Med 2002; 64: 510\u2013519.","journal-title":"Biopsychosoc Sci Med"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4135\/9781452232966"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5411"},{"key":"e_1_3_3_31_2","volume-title":"Manual for the state-trait anxiety inventory","author":"Spielberger CD","year":"1970","unstructured":"Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Consulting Psychologists Press, 1970."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/014662167700100306"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-016-0055-3"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-017-0067-7"},{"key":"e_1_3_3_35_2","first-page":"36","article-title":"Family caregiving in dementia","volume":"94","author":"Tremont G","year":"2011","unstructured":"Tremont G. Family caregiving in dementia. Med Health R I 2011; 94: 36.","journal-title":"Med Health R I"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3696-3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.987936"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18937"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261471921","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261471921","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261471921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:10:05Z","timestamp":1789459805000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261471921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/13872877261471921"],"URL":"https:\/\/doi.org\/10.1177\/13872877261471921","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}